YourLawyer.com 1-800-LAW-INFO (1-800-529-4636)

Parker Waichman Alonso LLP Headlines by Topic

Trasylol

Trasylol Gone for Good

May 15, 2008 | Parker Waichman Alonso LLP
Trasylol is being removed from the market for good.  Bayer AG had suspended marketing of Trasylol, a drug used to prevent bleeding during heart...

Trasylol Named in 78 Lawsuits, Bayer Says

Apr 28, 2008 | Parker Waichman Alonso LLP
Bayer AG has been hit with 78 lawsuits over the drug Trasylol.  In November, Bayer suspended Trasylol sales after a Canadian study linked it to...

More Trasylol Studies -- One Previously Withheld by Bayer -- Confirm Death Risks

Feb 21, 2008 | Parker Waichman Alonso LLP
Two more Trasylol studies have concluded that heart surgery patients are more likely to die if treated with the defective drug.  Trasylol,...

FDA Trasylol Failure Could Have Killed Thousands, Researcher Says

Feb 15, 2008 | Parker Waichman Alonso LLP
Trasylol, a defective drug manufactured by Bayer AG, may have killed 22,000 people before it was pulled from the market last year.  Trasylol was...

Trasylol Drug Combo Linked to Deaths

Feb 12, 2008 | Parker Waichman Alonso LLP
A new Trasylol study is shedding more light on possible reasons behind the drug’s higher-than normal death rate.  According to British...

Trasylol Sales Suspended After Canadian Study Links Drug to Sudden Death Risk

Nov 26, 2007 | Parker Waichman Alonso LLP
Trasylol, a drug used to prevent bleeding during heart surgery, was removed from the market by Bayer AG earlier this month after it was linked to a...

Trasylol Deaths Exceed 200, FDA Says

Nov 19, 2007 | Parker Waichman Alonso LLP
Trasylol, a defective drug made by Bayer AG, may have killed more than 200 people, according to the Food & Drug Administration (FDA). ...

Trasylol Pulled From World Market by Bayer AG

Nov 7, 2007 | Parker Waichman Alonso LLP
Trasylol, an anti-bleeding medication, was pulled from the market earlier this week following concerns that it put patients at a high risk of...

Trasylol to Undergo another FDA Safety Review After Canada Halts Clinical Trial

Oct 29, 2007 | Parker Waichman Alonso LLP
Trasylol will be the subject of yet another Food & Drug Administration (FDA) safety review, after a clinical trial involving the drug was halted...

Trasylol Clinical Trail Halted Due to Bleeding, Death Risk

Oct 25, 2007 | Parker Waichman Alonso LLP
A Trasylol clinical trial has been halted according to the  Food & Drug Administration (FDA) because patients enrolled in the study who took...

Page 1/3 [first] [prev] 1 2 3 [next] [last]

Trasylol
* Denotes required field.

Title

* First Name

* Last Name

* Email Address

* Phone Number

Cell Phone Number

Office Phone Number

Street Address

Apartment/Suite

City

State

Zip Code

Please provide the best method and times to contact you:

Date of birth of person injured
(mm-dd-yyyy):

Date of surgery:

Have you (or injured party) experienced any of the following:





Did you (or injured party) require dialysis?


Please describe any side effects:

Other Info:

No Yes, I agree to the Parker Waichman Alonso LLP disclaimers.Click here to review all.

Yes, I would like to receive the Parker Waichman Alonso LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Home | Defective Drugs | Medical Devices | Toxic Substances | Accidents | Product Liability | Malpractice | Diseases
Nursing Home Negligence | Food Poisoning | Other Topics | Contact
Statement of Clients' Rights | Site Map | ReNu with MoistureLoc | Vioxx | Mesothelioma | Permax | Dostinex | Composix Kugel Mesh X Large Patch
Ortho Evra | Fosamax | Personal Injury Lawyer | Fusarium Keratitis | Stevens Johnson Syndrome

© 2002-2008 YourLawyer.com. All Rights Reserved.

Please note that you are not considered a client until you have signed a retainer agreement and your case has been accepted by us.
Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Attorney Advertising

Parker Waichman Personal Injury News